ORIGINAL PAPER
Prevalence of pregnancy complications in the Świętokrzyskie province: a follow-up of a cohort of patients participating in first-trimester prenatal screening tests
1
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2
Department of Obstetrics and Gynecology, Voivodeship Hospital Complex, Kielce, Poland
Submission date: 2023-07-10
Final revision date: 2024-06-20
Acceptance date: 2024-09-06
Publication date: 2024-12-16
Corresponding author
Jakub Młodawski
Jakub Młodawski Collegium Medicum Jan Kochanowski University Kielce, Poland
Jakub Młodawski Collegium Medicum Jan Kochanowski University Kielce, Poland
Medical Studies 2024;40(4):341-346
KEYWORDS
TOPICS
ABSTRACT
Introduction:
This study addresses the scarcity of detailed epidemiological data in Poland and presents an rate of pregnancy complications in the Świętokrzyskie province. A follow-up on patients who underwent first-trimester prenatal screening at the Prenatal Testing Clinic of the Voivodeship Hospital Complex in Kielce was conducted, providing valuable regional data.
Aim of the research:
The aim of the study was to record the prevalence of selected pregnancy complications in the Świętokrzyskie province, utilizing a retrospective study of medical records.
Material and methods:
The study encompassed 1212 patients who underwent first-trimester prenatal screening tests in 2018–2019. These patients subsequently gave birth at the Department of Obstetrics and Gynecology of the Voivodeship Hospital Complex in Kielce. The study involved compiling data on various pregnancy complications such as fetal growth restriction, gestational diabetes, arterial hypertension, and more.
Results:
Among pregnancy complications, fetal growth restriction (FGR) occurred in 2.20% of cases, with 34.60% diagnosed before 32 weeks and 65.40% after. Gestational diabetes was noted in 14.80% of pregnancies, with 51.40% managed with diet and 46.90% with insulin. Arterial hypertension affected 7.60%, including pregnancy-induced hypertension (61.80%) and chronic hypertension (14.50%). Preeclampsia was observed in 1.40% of cases. Preterm prelabor rupture of membranes (PPROM) occurred in 3.60%, while cervical insufficiency requiring cerclage was seen in 1.65%. Placenta-related complications included placenta previa (0.41%) and placenta accreta spectrum (0.21%).
Conclusions:
The study provided essential insights into the prevalence of pregnancy complications in the Świętokrzyskie province, revealing that rates are generally in line with global trends. It underscores the need for continued research and monitoring of these trends to optimize health outcomes.
This study addresses the scarcity of detailed epidemiological data in Poland and presents an rate of pregnancy complications in the Świętokrzyskie province. A follow-up on patients who underwent first-trimester prenatal screening at the Prenatal Testing Clinic of the Voivodeship Hospital Complex in Kielce was conducted, providing valuable regional data.
Aim of the research:
The aim of the study was to record the prevalence of selected pregnancy complications in the Świętokrzyskie province, utilizing a retrospective study of medical records.
Material and methods:
The study encompassed 1212 patients who underwent first-trimester prenatal screening tests in 2018–2019. These patients subsequently gave birth at the Department of Obstetrics and Gynecology of the Voivodeship Hospital Complex in Kielce. The study involved compiling data on various pregnancy complications such as fetal growth restriction, gestational diabetes, arterial hypertension, and more.
Results:
Among pregnancy complications, fetal growth restriction (FGR) occurred in 2.20% of cases, with 34.60% diagnosed before 32 weeks and 65.40% after. Gestational diabetes was noted in 14.80% of pregnancies, with 51.40% managed with diet and 46.90% with insulin. Arterial hypertension affected 7.60%, including pregnancy-induced hypertension (61.80%) and chronic hypertension (14.50%). Preeclampsia was observed in 1.40% of cases. Preterm prelabor rupture of membranes (PPROM) occurred in 3.60%, while cervical insufficiency requiring cerclage was seen in 1.65%. Placenta-related complications included placenta previa (0.41%) and placenta accreta spectrum (0.21%).
Conclusions:
The study provided essential insights into the prevalence of pregnancy complications in the Świętokrzyskie province, revealing that rates are generally in line with global trends. It underscores the need for continued research and monitoring of these trends to optimize health outcomes.
REFERENCES (33)
1.
Porta M. A Dictionary of Epidemiology. 6th ed. Oxford: Oxford University Press; 2014. Available from: https://www.oxfordreference.co.... Accessed June 16, 2024.
3.
Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 7th ed. New York: John Wiley & Sons; 1999.
4.
Central Statistical Office. Statistical Yearbook of the CSO 2023. Warsaw: CSO; 2023. Available from: https://stat.gov.pl/obszary-te.... Accessed June 16, 2024.
5.
Mastrodima S, Akolekar R, Yerlikaya G, Tzelepis T, Nicolaides KH. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks. Ultrasound Obstet Gynecol. 2016 Nov; 48(5): 613-617.
6.
Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022; 226 (2 Suppl): S1071-S1097.e2.
7.
Papastefanou I, Nowacka U, Syngelaki A, Dragoi V, Karamanis G, Wright D, Nicolaides KH. Competing-risks model for prediction of small-for-gestational-age neonate from estimated fetal weight at 19–24 weeks’ gestation. Ultrasound Obstet Gynecol. 2021; 57: 917-924.
8.
Arain Z, Iliodromiti S, Slabaugh G, David AL, Chowdhu- ry TT. Machine learning and disease prediction in obstetrics. Curr Res Physiol. 2023 May 19; 6: 100099.
9.
Safari S, Baratloo A, Elfil M, Negida A. Evidence Based Emergency Medicine; Part 4: Pre-test and Post-test Probabilities and Fagan’s nomogram. Emerg (Tehran). 2016 Winter; 4(1): 48-51.
10.
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013 Sep; 170(1): 1-7.
11.
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngela- ki A, de Paco Matallana C, Akolekar R, Cicero S, Jan- ga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurar- son S, Maclagan K, Nicolaides KH. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017 Aug 17; 377(7): 613-622.
12.
Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016; 353. doi: 10.1136/bmj.i1753.
13.
World Health Organization. Obesity; 2021. Available from: https://www.euro.who.int/en/he.... Accessed June 16, 2023.
14.
Stival C, Lugo A, Odone A, van den Brandt PA, Fernan- dez E, Tigova O, Soriano JB, López MJ, Scaglioni S, Gal- lus S; Investigators TackSHS Project. Prevalence and correlates of overweight and obesity in 12 European countries in 2017-2018. Obes Facts. 2022; 15(5): 655-665.
15.
Obata S, Toda M, Tochio A, Hoshino A, Miyagi E, Aoki S. Fetal growth restriction as a diagnostic criterion for preeclampsia. Pregnancy Hypertens. 2020 Jul; 21: 58-62.
16.
Lawn JE, Ohuma EO, Bradley E, Idueta LS, Hazel E, Okwaraji YB, Erchick DJ, Yargawa J, Katz J, Lee AC, Diaz M, Salasibew M, Requejo J, Hayashi C. Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting. Lancet. 2023 May 20; 401(10389): 1707-1719.
17.
Lees CC, Stampalija T, Baschat A, da Silva Costa F, Ferraz- zi E, Figueras F, Hecher K, Kingdom J, Poon LC, Salo- mon LJ, Unterscheider J. SUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. 2020 Aug; 56(2): 298-312.
18.
Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014 Feb; 103(2): 176-185.
19.
Suliga E, Głuszek-Osuch M, Głuszek S. Prevalence and factors related to the metabolically obese normal weight (MONW) phenotype: a review. Med Stud. 2023; 39(1): 73-90.
20.
International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer Ar, de Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJN, Omori Y, Schmidt MI. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010 Mar; 33(3): 676-682.
21.
Chi C, Loy SL, Chan SY, Choong C, Cai S, Soh SE, Tan KH, Yap F, Gluckman PD, Godfrey KM, Pei-Chi Shek L, Chan JKY, Kramer MS, Chong YS. Impact of adopting the 2013 World Health Organization criteria for diagnosis of gestational diabetes in a multi-ethnic Asian cohort: a prospective study. BMC Pregnancy Childbirth. 2018; 18: 69.
22.
Aubry EM, Raio L, Oelhafen S. Effect of the IADPSG screening strategy for gestational diabetes on perinatal outcomes in Switzerland. Diabetes Res Clin Pract. 2021; 175: 108830.
23.
Carreiro MP, Nogueira AI, Ribeiro-Oliveira A. Controversies and advances in gestational diabetes-an update in the era of continuous glucose monitoring. J Clin Med. 2018 Jan; 7(2): 11.
24.
Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen. 2002; 9(3): 135-141.
25.
Çakırca TD, Can İN, Deniz M, Torun A, Akçabay Ç, Güzelçiçek A. Toxoplasmosis: a timeless challenge for pregnancy. Trop Med Infect Dis. 2023; 8(1): 63.
26.
Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Ren- ton JL, Hedman K, Remington JS. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol. 1997; 35(1): 174-178.
27.
Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019 Sep; 221(3): 208-218.
28.
Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Med. 2003 Mar; 13(3): 175-190.
29.
Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am. 2005 Sep; 32(3): 411-428.
30.
Nicholls-Dempsey L, Badeghiesh A, Baghlaf H, Da- han MH. How does high socioeconomic status affect maternal and neonatal pregnancy outcomes? A population-based study among American women. Eur J Obstet Gynecol Reprod Biol X. 2023 Oct 12; 20: 100248.
31.
Ghosh G, Grewal J, Männistö T, Mendola P, Chen Z, Xie Y, Laughon SK. Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women. Ethn Dis. 2014 Summer; 24(3): 283-289.
32.
Bomba-Opoń D, Drews K, Huras H, Laudański P, Paszkowski T, Wielgoś M. Polish gynecological society recommendations for labor induction. Ginekol Pol. 2017; 88(4): 224-234.
33.
Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 188: Prelabor Rupture of Membranes. Obstet Gynecol. 2018 Jan; 131(1): e1-E14.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
